1-4 of 4
Maria Socorro O. Portella
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Durability of Eltrombopag Clinical Benefit for Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia and Severe Thrombocytopenia (ASPIRE Part 3)

Moshe Mittelman, MD, Uwe Platzbecker, MD, Boris Afanasyev, MD PhD, Sebastian Grosicki, MD PhD, Maria Socorro O Portella, MD MBA, Zewen Zhu, Dominik Selleslag, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3740.
https://doi.org/10.1182/blood-2019-130309
Published: 2019
Journal Articles

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Clinical Trials & Observations
Michael Dickinson, Honar Cherif, Pierre Fenaux, Moshe Mittelman, Amit Verma, Maria Socorro O. Portella, Paul Burgess, Pedro Marques Ramos, Jeea Choi, Uwe Platzbecker
Journal: Blood
Blood (2018) 132 (25): 2629–2638.
https://doi.org/10.1182/blood-2018-06-855221
Published: 2018
Includes: Supplemental data
Journal Articles

Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study

Clinical Trials & Observations
Raymond S. M. Wong, Mansoor N. Saleh, Abderrahim Khelif, Abdulgabar Salama, Maria Socorro O. Portella, Paul Burgess, James B. Bussel
Journal: Blood
Blood (2017) 130 (23): 2527–2536.
https://doi.org/10.1182/blood-2017-04-748707
Published: 2017
Includes: Supplemental data
Journal Articles

Thrombopoietin (TPO) Receptor Agonist Eltrombopag in Combination with Azacitidine (AZA) for Primary Treatment of Myelodysplastic Syndromes (MDS) Patients with Thrombocytopenia: Outcomes from the Randomized, Placebo-Controlled, Phase III Support Study

Michael J. Dickinson, MBBS, FRACP, FRCPA, Honor Cherif, Pierre Fenaux, Moshe Mittleman, Amit Verma, MD, Maria Socorro O Portella, MD, Paul Burgess, Uwe Platzbecker, MD
Journal: Blood
Blood (2016) 128 (22): 163.
https://doi.org/10.1182/blood.V128.22.163.163
Published: 2016